We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants
ZIVOW

Delisted

ZIVOW was delisted on the 24th of November, 2023.

Back to rankings

4 hedge funds and large institutions have $109K invested in Zivo Bioscience, Inc. Warrants in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more capital invested

Capital invested by funds: $81K → $109K (+$28.2K)

20% less funds holding

Funds holding: 5 → 4 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
+$19.5K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$417
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$65.3K +$19.5K +25,655 +30%
AC
2
Ayrton Capital
Connecticut
$28.5K – – –
CH
3
CVI Holdings
Delaware
$9.5K – – –
VCA
4
Verdence Capital Advisors
Maryland
$5.83K – – –
UBS Group
5
UBS Group
Switzerland
– -$417 -5,955 Closed

ZIVOW Hedge Fund Activity: Q1 2023 in Review

4 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q1 2023, worth a combined $109K — up 35% from $81K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ZIVOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Warberg Asset Management, adding an estimated $19.5K. The largest seller was UBS Group, exiting entirely with an estimated $417 sold.

  • 4 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q1 2023, down from 5 in Q4 2022.
  • Funds reported $109K of Zivo Bioscience, Inc. Warrants stock for Q1 2023, up 35% quarter-over-quarter.
  • 0 funds opened new Zivo Bioscience, Inc. Warrants positions in Q1 2023 and 1 closed out, a net change of -1 holder.
  • The largest Zivo Bioscience, Inc. Warrants buyer in Q1 2023 was Warberg Asset Management, an estimated $19.5K added.
  • The largest Zivo Bioscience, Inc. Warrants seller in Q1 2023 was UBS Group, an estimated $417 sold.

Based on aggregated 13F filings for Q1 2023.